NewAmsterdam Pharma Announces Appointment Of Ian Somaiya As Chief Financial Officer
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of cardiovascular disease with residual elevation of low-density